Awareness, Care & Treatment In Obesity Management - An Observation in Mainland China
ACTION China
2 other identifiers
observational
8,000
1 country
1
Brief Summary
ACTION China is a cross-sectional, observational, descriptive, and exploratory survey-based study without collection of laboratory data. The study is not related to any specific treatment options or pharmaceutical product. Collection of data will be performed via quantitative online survey by a third-party vendor. The goal of this study is to provide insights to drive awareness around the needs of People Living with Obesity (PLwO) and Health Care Professionals (HCPs) involved in obesity treatment and management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 19, 2022
CompletedFirst Posted
Study publicly available on registry
June 23, 2022
CompletedStudy Start
First participant enrolled
August 18, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2022
CompletedSeptember 19, 2024
September 1, 2024
3 months
May 19, 2022
September 6, 2024
Conditions
Outcome Measures
Primary Outcomes (8)
Weight loss motivators
Multi-selection from defined list
Day 1-day of survey
PLwO / participants who made serious weight loss effort
Percentage of participants
Day 1-day of survey
Response to/evaluation of weight loss discussion according to predefined list of values
Single selection from defined list 1. Not at all helpful 2. A little helpful 3. Somewhat helpful 4. Very helpful 5. Extremely helpful
Day 1-day of survey
Effective weight loss methods
Multi-selection from defined list
Day 1-day of survey
Obesity attitudes
5-point Likert scales: 1: Do not agree at all 5: Completely agree
Day 1-day of survey
Attitudes toward prescription weight loss medication and surgery
5-point Likert scales: 1: Do not agree at all 5: Completely agree
Day 1-day of survey
Agreement with predefined Obesity and weight management measures
5-point Likert scales: 1: Do not agree at all 5: Completely agree
Day 1-day of survey
Degree to which healthcare and society is meeting needs of PLwO
5-point Likert scales: 1: Not at all meeting the needs 5: Completely meeting the needs
Day 1-day of survey
Secondary Outcomes (8)
Weight loss barriers
Day 1-day of survey
Top factors for improving weight loss outcomes
Day 1-day of survey
Types of weight management goals
Day 1-day of survey
Most helpful information for participants for weight loss
Day 1-day of survey
Responsibility for improving health of PLwO (rank of individuals/organizations in order of their responsibility)
Day 1-day of survey
- +3 more secondary outcomes
Study Arms (2)
Person Living with Obesity (PLwO)
PLwO recruited via online platforms or face-to-face channels
Health Care Professionals (HCPs)
HCPs treating people who have obesity
Interventions
People / Person Living with Obesity (PLwO) Health Care Professionals (HCPs)
Eligibility Criteria
The respondent population will include people living with obesity (PLwO) and health care professionals (HCPs) involved in obesity treatment and management
You may qualify if:
- PLwO:
- Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
- Male or female, aged above or equal to 18 years at the time of signing informed consent
- Lives in mainland China and is native Chinese
- Current BMI based on self-reported height and weight of at least 28 kg/m\^2 as per mainland China definition of obesity(16) (calculated using an algorithm within the survey instrument)
- HCPs:
- Informed consent obtained before any study related activities (study-related activities are any procedure related to recording/collection of data according to the protocol)
- Male or female, aged greather than or equal to18 years at the time of signing informed consent.
- Physician with a license to practice
- Specialty is not surgeon (including general, bariatric or plastic surgeon)
- Practices in mainland China with at least 5 years in clinical practice
- Spends at least 50% of time in direct patient care (as opposed to surgical procedures, office procedures or research/administrative tasks)
- Has seen at least 100 patients in the past month
- Has seen at least 10 patients needing weight management (defined as a patient with a BMI greather than or equal to28 kg/m\^2 with or without comorbidities) in the past month
You may not qualify if:
- PLwO
- \. Previous participation in this study. Participation is defined as having given online consent in this study 2. Currently pregnant 3. Participates in intense fitness or body building programs 4. Has had significant, unintentional weight loss (due to major injury, illness, etc) in the past 6 months 5. Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation HCPs
- Previous participation in this study. Participation is defined as having given informed consent in this study.
- Unwillingness, inability, or language barriers precluding adequate understanding or cooperation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Novo Nordisk A/Slead
Study Sites (1)
Novo Nordisk Investigational Site
Beijing, China
Related Publications (2)
Ji L, Mu Y, Chang C, Wang H, Zhao D, Liu D, Shen Z, Chen W. Perceptions, attitudes and barriers to effective obesity care among people living with obesity and healthcare professionals in China: The ACTION-China study. Diabetes Obes Metab. 2024 Oct;26(10):4694-4704. doi: 10.1111/dom.15837. Epub 2024 Aug 9.
PMID: 39119627RESULTLuo Y, Mu Y, Chen W, Wang H, Zhao D, Liu D, Zhang J, Ji L. Attitudes towards therapeutic options for weight management, including weight loss medications and surgery, among people living with obesity and healthcare professionals in China: A secondary analysis from the ACTION-China study. Diabetes Obes Metab. 2025 Jul;27(7):3627-3634. doi: 10.1111/dom.16369. Epub 2025 Apr 15.
PMID: 40230237DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Clinical Transparency (dept. 2834)
Novo Nordisk A/S
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 19, 2022
First Posted
June 23, 2022
Study Start
August 18, 2022
Primary Completion
November 30, 2022
Study Completion
November 30, 2022
Last Updated
September 19, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will share
According to the Novo Nordisk disclosure commitment on novonordisk-trials.com